Cleared Traditional

K872070 - CHROMOTITRE E.I.A. TOXOPLASMA IGM

K872070 is an FDA 510(k) clearance for CHROMOTITRE E.I.A. TOXOPLASMA IGM, manufactured by Ismunit Istituto Immunologico Intaliano. The device is a Class 2 Microbiology device with product code LGD cleared through the Traditional 510(k) pathway after a 144-day FDA review.

K872070 · Ismunit Istituto Immunologico Intaliano · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1987
Decision
144d
Days
Class 2
Risk

K872070 is an FDA 510(k) clearance for the CHROMOTITRE E.I.A. TOXOPLASMA IGM. Classified as Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii (product code LGD), Class II - Special Controls.

Submitted by Ismunit Istituto Immunologico Intaliano (Roma, IT). The FDA issued a Cleared decision on October 20, 1987 after a review of 144 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3780 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Ismunit Istituto Immunologico Intaliano devices

FDA 510(k) Submission Details - K872070

510(k) Number K872070 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 29, 1987
Decision Date October 20, 1987
Days to Decision 144 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
42d slower than avg
Panel avg: 102d · This submission: 144d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LGD Device Classification - Class 2, Special Controls

Product Code LGD Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3780
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LGD Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii

All 96
Devices cleared under the same product code (LGD) and FDA review panel - the closest regulatory comparables to K872070.
TOXOSTAT M TEST KIT
K875113 · Whittaker Bioproducts, Inc. · Apr 1988
TOXOPLASMA IGM CLIN-ELISA(TM) CAT # 5560
K874594 · Clinical Sciences, Inc. · Mar 1988
DETECTADOT SYSTEM 2000 TOXO IGG TEST
K875109 · Gull Laboratories, Inc. · Mar 1988
CAPTIA(R) TOXO-M: AN ENZYME IMMUNOASSAY
K871746 · Mercia Diagnostics , Ltd. · Jul 1987
TOXOPLASMA GONDII IGG ELISA
K871905 · Electro-Nucleonics Laboratories, Inc. · Jul 1987
MODIFIED TOXOPLASMA GONDII IGG EIA TEST KIT
K872252 · Labsystems, Inc. · Jul 1987